Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pou3f2
|
ENSMUSG00000095139.1 | POU domain, class 3, transcription factor 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_22478554_22478820 | Pou3f2 | 9679 | 0.166492 | 0.95 | 8.6e-28 | Click! |
chr4_22479124_22479682 | Pou3f2 | 8963 | 0.167808 | 0.95 | 1.7e-27 | Click! |
chr4_22488420_22489023 | Pou3f2 | 355 | 0.826507 | 0.95 | 1.7e-27 | Click! |
chr4_22478018_22478185 | Pou3f2 | 10265 | 0.165521 | 0.94 | 6.0e-26 | Click! |
chr4_22487751_22488274 | Pou3f2 | 354 | 0.841636 | 0.94 | 7.3e-26 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_88206531_88206915 | 29.30 |
Gm3764 |
predicted gene 3764 |
90 |
0.91 |
chr4_107834863_107835108 | 29.17 |
Lrp8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
4000 |
0.13 |
chr14_123064863_123065073 | 28.05 |
AA536875 |
expressed sequence AA536875 |
21686 |
0.22 |
chr16_89538151_89538450 | 25.70 |
Krtap7-1 |
keratin associated protein 7-1 |
29977 |
0.13 |
chr13_84064376_84064611 | 24.53 |
Gm17750 |
predicted gene, 17750 |
279 |
0.93 |
chr16_45999918_46000199 | 21.76 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
10160 |
0.16 |
chr13_15544401_15544592 | 21.58 |
Gli3 |
GLI-Kruppel family member GLI3 |
80516 |
0.08 |
chr9_60460061_60460212 | 21.13 |
Thsd4 |
thrombospondin, type I, domain containing 4 |
36990 |
0.12 |
chr10_87351663_87352183 | 20.94 |
Gm23191 |
predicted gene, 23191 |
12223 |
0.23 |
chr13_11099319_11099546 | 20.81 |
Gm47486 |
predicted gene, 47486 |
125009 |
0.06 |
chr6_47367638_47368002 | 20.31 |
Gm18584 |
predicted gene, 18584 |
65269 |
0.11 |
chr12_72235750_72235907 | 20.20 |
Rtn1 |
reticulon 1 |
89 |
0.98 |
chrX_49288183_49288615 | 19.93 |
Enox2 |
ecto-NOX disulfide-thiol exchanger 2 |
140 |
0.97 |
chr3_34104007_34104173 | 19.77 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
180 |
0.93 |
chr14_113469187_113469363 | 19.03 |
Gm4487 |
predicted gene 4487 |
21385 |
0.28 |
chr2_65932084_65932307 | 18.96 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
330 |
0.9 |
chr14_104538063_104538407 | 18.92 |
Rnf219 |
ring finger protein 219 |
15590 |
0.18 |
chr8_41054736_41055125 | 18.65 |
Mtus1 |
mitochondrial tumor suppressor 1 |
136 |
0.94 |
chr14_60554058_60554987 | 18.62 |
Gm47810 |
predicted gene, 47810 |
42380 |
0.15 |
chr1_22806793_22806944 | 18.38 |
Rims1 |
regulating synaptic membrane exocytosis 1 |
874 |
0.72 |
chr18_56282512_56282736 | 18.33 |
Gm50385 |
predicted gene, 50385 |
2228 |
0.36 |
chr15_66286727_66287219 | 18.24 |
Gm27242 |
predicted gene 27242 |
56 |
0.82 |
chr18_44520470_44520631 | 18.24 |
Mcc |
mutated in colorectal cancers |
1034 |
0.65 |
chr5_19982062_19982213 | 17.90 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
74176 |
0.11 |
chr10_13107920_13108404 | 17.72 |
Plagl1 |
pleiomorphic adenoma gene-like 1 |
5303 |
0.23 |
chr1_5022831_5023607 | 17.63 |
Rgs20 |
regulator of G-protein signaling 20 |
3680 |
0.21 |
chr9_35482376_35482537 | 17.58 |
Gm25630 |
predicted gene, 25630 |
7571 |
0.13 |
chr10_87489779_87490093 | 17.45 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
3724 |
0.24 |
chr15_84069503_84069654 | 17.44 |
Efcab6 |
EF-hand calcium binding domain 6 |
4199 |
0.17 |
chr1_20823916_20824295 | 17.11 |
Gm20587 |
predicted gene, 20587 |
2774 |
0.16 |
chr8_55104196_55104391 | 17.10 |
Gm8734 |
predicted gene 8734 |
22578 |
0.16 |
chr7_117618964_117619337 | 17.01 |
Xylt1 |
xylosyltransferase 1 |
143658 |
0.05 |
chr10_87419692_87419877 | 16.82 |
Gm23191 |
predicted gene, 23191 |
55638 |
0.12 |
chr13_34096148_34096452 | 16.55 |
Gm47065 |
predicted gene, 47065 |
7273 |
0.1 |
chr3_16938457_16938677 | 16.52 |
Gm26485 |
predicted gene, 26485 |
115255 |
0.07 |
chr8_37291540_37291737 | 16.49 |
Gm25126 |
predicted gene, 25126 |
25940 |
0.16 |
chr2_141954926_141955125 | 16.48 |
Fau-ps1 |
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived), pseudogene 1 |
116236 |
0.07 |
chr2_57375175_57375384 | 16.44 |
Gm13531 |
predicted gene 13531 |
50430 |
0.15 |
chr13_28810449_28810625 | 16.35 |
Gm17528 |
predicted gene, 17528 |
16586 |
0.19 |
chr7_39588137_39588315 | 15.99 |
Gm2058 |
predicted gene 2058 |
705 |
0.58 |
chr14_117895288_117895467 | 15.90 |
Mir6239 |
microRNA 6239 |
58470 |
0.14 |
chr7_54782042_54782216 | 15.80 |
Luzp2 |
leucine zipper protein 2 |
53369 |
0.15 |
chr12_47162854_47163202 | 15.63 |
Gm36971 |
predicted gene, 36971 |
2014 |
0.43 |
chr4_85763444_85763598 | 15.61 |
Adamtsl1 |
ADAMTS-like 1 |
249194 |
0.02 |
chr19_14435617_14435984 | 15.48 |
Tle4 |
transducin-like enhancer of split 4 |
159739 |
0.04 |
chr1_46830543_46830706 | 15.47 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5275 |
0.22 |
chr18_23040919_23041185 | 15.44 |
Nol4 |
nucleolar protein 4 |
601 |
0.84 |
chr16_77851555_77851719 | 15.41 |
Gm17333 |
predicted gene, 17333 |
5033 |
0.28 |
chr6_10969635_10970167 | 15.38 |
AA545190 |
EST AA545190 |
4477 |
0.3 |
chr3_17797861_17798083 | 15.24 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
2228 |
0.25 |
chr8_69122168_69122328 | 15.20 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
18705 |
0.14 |
chr15_42047422_42047615 | 15.20 |
Gm49438 |
predicted gene, 49438 |
8622 |
0.18 |
chr13_78602164_78602454 | 15.19 |
Gm48402 |
predicted gene, 48402 |
35708 |
0.21 |
chr9_29862513_29862691 | 15.16 |
Ntm |
neurotrimin |
100517 |
0.08 |
chr12_116677727_116678076 | 15.15 |
Gm17807 |
predicted gene, 17807 |
80648 |
0.09 |
chr13_35345593_35345770 | 15.07 |
Gm48703 |
predicted gene, 48703 |
49702 |
0.12 |
chr12_12432821_12432972 | 15.03 |
4921511I17Rik |
RIKEN cDNA 4921511I17 gene |
40281 |
0.2 |
chr4_141541952_141542136 | 15.01 |
Spen |
spen family transcription repressor |
3447 |
0.16 |
chr3_127713384_127713535 | 15.00 |
1500005C15Rik |
RIKEN cDNA 1500005C15 gene |
3568 |
0.14 |
chr14_17089811_17089962 | 14.94 |
Gm18927 |
predicted gene, 18927 |
15675 |
0.23 |
chr3_62348500_62348904 | 14.94 |
Arhgef26 |
Rho guanine nucleotide exchange factor (GEF) 26 |
7601 |
0.24 |
chr2_124176756_124177153 | 14.86 |
Sema6d |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
33949 |
0.18 |
chr3_63871310_63871507 | 14.78 |
Plch1 |
phospholipase C, eta 1 |
20049 |
0.13 |
chr19_18889230_18889551 | 14.70 |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
48753 |
0.16 |
chr14_17722808_17722982 | 14.65 |
Gm48320 |
predicted gene, 48320 |
48227 |
0.17 |
chrX_110811168_110811444 | 14.61 |
Gm44593 |
predicted gene 44593 |
1018 |
0.58 |
chr1_38849080_38849231 | 14.57 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
12444 |
0.16 |
chr16_42575508_42575977 | 14.51 |
Gm49739 |
predicted gene, 49739 |
88184 |
0.1 |
chr2_152047040_152047574 | 14.40 |
AA387200 |
expressed sequence AA387200 |
29501 |
0.11 |
chr1_42703489_42704501 | 14.39 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4057 |
0.16 |
chr16_44531342_44531584 | 14.35 |
Mir3081 |
microRNA 3081 |
26666 |
0.17 |
chr17_9023270_9023497 | 14.23 |
1700010I14Rik |
RIKEN cDNA 1700010I14 gene |
35000 |
0.18 |
chr12_48959427_48959578 | 14.20 |
Gm26454 |
predicted gene, 26454 |
50381 |
0.16 |
chr1_155693534_155693775 | 14.18 |
Acbd6 |
acyl-Coenzyme A binding domain containing 6 |
6663 |
0.21 |
chr10_25311558_25311709 | 14.16 |
Akap7 |
A kinase (PRKA) anchor protein 7 |
3763 |
0.21 |
chr10_23674681_23675112 | 14.02 |
4930520K02Rik |
RIKEN cDNA 4930520K02 gene |
52748 |
0.11 |
chr10_100865613_100865813 | 14.01 |
Gm35722 |
predicted gene, 35722 |
124078 |
0.05 |
chr12_89699466_89699833 | 13.98 |
Gm48692 |
predicted gene, 48692 |
43926 |
0.2 |
chr6_126768206_126768472 | 13.94 |
Kcna6 |
potassium voltage-gated channel, shaker-related, subfamily, member 6 |
27665 |
0.13 |
chr6_31933580_31933731 | 13.93 |
1700012A03Rik |
RIKEN cDNA 1700012A03 gene |
116591 |
0.06 |
chr2_167201609_167201760 | 13.91 |
Gm14291 |
predicted gene 14291 |
108 |
0.95 |
chrX_42361720_42361910 | 13.80 |
Gm14619 |
predicted gene 14619 |
14303 |
0.27 |
chr17_37072712_37072897 | 13.78 |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
2360 |
0.14 |
chr16_77645068_77645328 | 13.74 |
Mir125b-2 |
microRNA 125b-2 |
1075 |
0.28 |
chr18_65254124_65254313 | 13.49 |
Mir122 |
microRNA 122 |
5357 |
0.16 |
chr7_136491174_136491643 | 13.43 |
Gm36849 |
predicted gene, 36849 |
138044 |
0.04 |
chr6_12337029_12337231 | 13.34 |
Thsd7a |
thrombospondin, type I, domain containing 7A |
12437 |
0.3 |
chr4_65699895_65700351 | 13.31 |
Trim32 |
tripartite motif-containing 32 |
94874 |
0.1 |
chr5_85572073_85572255 | 13.29 |
Gm43567 |
predicted gene 43567 |
148610 |
0.05 |
chr8_67972439_67972650 | 13.24 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
2030 |
0.35 |
chr2_21270386_21270595 | 13.17 |
Gm13378 |
predicted gene 13378 |
26385 |
0.17 |
chr1_25179942_25180227 | 13.17 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
24639 |
0.16 |
chr16_87916566_87916764 | 13.14 |
Grik1 |
glutamate receptor, ionotropic, kainate 1 |
7166 |
0.29 |
chr3_115774445_115774621 | 12.94 |
Gm9889 |
predicted gene 9889 |
59383 |
0.1 |
chr4_57091378_57091763 | 12.92 |
Epb41l4b |
erythrocyte membrane protein band 4.1 like 4b |
11883 |
0.23 |
chr3_17619540_17619872 | 12.92 |
Gm38154 |
predicted gene, 38154 |
50982 |
0.17 |
chr11_82579895_82580440 | 12.92 |
Gm24612 |
predicted gene, 24612 |
16012 |
0.2 |
chr18_21625323_21625535 | 12.90 |
4930426D05Rik |
RIKEN cDNA 4930426D05 gene |
26019 |
0.2 |
chr11_25357588_25357739 | 12.88 |
4933427E13Rik |
RIKEN cDNA 4933427E13 gene |
27706 |
0.22 |
chr4_13797055_13797354 | 12.88 |
Runx1t1 |
RUNX1 translocation partner 1 |
12422 |
0.29 |
chr1_66655202_66655398 | 12.87 |
Unc80 |
unc-80, NALCN activator |
18430 |
0.16 |
chr3_10891889_10892079 | 12.81 |
Gm22795 |
predicted gene, 22795 |
83602 |
0.09 |
chr13_84804703_84804898 | 12.79 |
Gm26913 |
predicted gene, 26913 |
113859 |
0.07 |
chr16_72959672_72959823 | 12.78 |
Robo1 |
roundabout guidance receptor 1 |
16602 |
0.29 |
chr5_83405334_83405587 | 12.77 |
Tecrl |
trans-2,3-enoyl-CoA reductase-like |
50265 |
0.15 |
chr16_77238528_77238890 | 12.76 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
2390 |
0.35 |
chr6_17187089_17187256 | 12.74 |
D830026I12Rik |
RIKEN cDNA D830026I12 gene |
10579 |
0.2 |
chr18_25378079_25378424 | 12.71 |
Gm16558 |
predicted gene 16558 |
13550 |
0.27 |
chr10_119819392_119819594 | 12.68 |
Grip1 |
glutamate receptor interacting protein 1 |
12 |
0.98 |
chr13_84571062_84571255 | 12.62 |
Gm26913 |
predicted gene, 26913 |
119783 |
0.06 |
chr3_45385503_45385751 | 12.52 |
Pcdh10 |
protocadherin 10 |
2994 |
0.22 |
chr8_71727942_71728505 | 12.51 |
Fcho1 |
FCH domain only 1 |
2507 |
0.15 |
chr13_105250811_105251272 | 12.50 |
Rnf180 |
ring finger protein 180 |
19998 |
0.22 |
chr17_55446826_55446977 | 12.45 |
St6gal2 |
beta galactoside alpha 2,6 sialyltransferase 2 |
657 |
0.77 |
chr3_57972679_57972830 | 12.44 |
Gm18867 |
predicted gene, 18867 |
10560 |
0.16 |
chr8_127774803_127774967 | 12.41 |
Gm22968 |
predicted gene, 22968 |
177179 |
0.03 |
chr5_150906447_150906658 | 12.36 |
Gm43298 |
predicted gene 43298 |
23910 |
0.17 |
chr13_83742140_83742347 | 12.36 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3380 |
0.15 |
chrX_93310384_93310605 | 12.31 |
Arx |
aristaless related homeobox |
23984 |
0.21 |
chr18_24959512_24959663 | 12.26 |
Fhod3 |
formin homology 2 domain containing 3 |
164774 |
0.03 |
chr14_93962365_93962563 | 12.25 |
Gm48981 |
predicted gene, 48981 |
19678 |
0.26 |
chr2_41498755_41498942 | 12.25 |
Lrp1b |
low density lipoprotein-related protein 1B |
290230 |
0.01 |
chr1_96773905_96774056 | 12.24 |
Gm26078 |
predicted gene, 26078 |
11949 |
0.24 |
chr2_55817883_55818034 | 12.15 |
Gm13517 |
predicted gene 13517 |
42410 |
0.21 |
chr2_96475744_96476057 | 12.14 |
Lrrc4c |
leucine rich repeat containing 4C |
157684 |
0.04 |
chr4_54029940_54030182 | 12.13 |
Gm24177 |
predicted gene, 24177 |
26004 |
0.22 |
chr7_96718538_96719200 | 12.12 |
Tenm4 |
teneurin transmembrane protein 4 |
59065 |
0.11 |
chr18_38067633_38067831 | 12.10 |
Gm30093 |
predicted gene, 30093 |
44203 |
0.09 |
chr3_88213791_88214095 | 12.09 |
Gm3764 |
predicted gene 3764 |
542 |
0.45 |
chr1_66320533_66320701 | 12.08 |
Map2 |
microtubule-associated protein 2 |
1102 |
0.5 |
chr16_90842198_90842666 | 12.01 |
Eva1c |
eva-1 homolog C (C. elegans) |
3966 |
0.16 |
chr15_25417935_25418396 | 11.97 |
Gm48957 |
predicted gene, 48957 |
3102 |
0.19 |
chr6_81661085_81661448 | 11.90 |
Gm26264 |
predicted gene, 26264 |
22955 |
0.21 |
chr1_168549901_168550223 | 11.89 |
Mir6348 |
microRNA 6348 |
59419 |
0.15 |
chr2_115056764_115057057 | 11.89 |
Gm13973 |
predicted gene 13973 |
19598 |
0.24 |
chr4_24429638_24429836 | 11.89 |
Gm27243 |
predicted gene 27243 |
1153 |
0.54 |
chr11_78786013_78786424 | 11.88 |
Gm23840 |
predicted gene, 23840 |
31696 |
0.11 |
chr7_81494080_81494231 | 11.86 |
Ap3b2 |
adaptor-related protein complex 3, beta 2 subunit |
230 |
0.87 |
chr10_21544028_21544189 | 11.84 |
1700020N01Rik |
RIKEN cDNA 1700020N01 gene |
49037 |
0.13 |
chr16_87841066_87841245 | 11.84 |
2810407A14Rik |
RIKEN cDNA 2810407A14 gene |
53583 |
0.13 |
chr4_5962185_5962388 | 11.83 |
Gm11796 |
predicted gene 11796 |
106799 |
0.07 |
chr7_58488234_58488397 | 11.75 |
Gm44852 |
predicted gene 44852 |
29847 |
0.2 |
chr13_110280472_110281172 | 11.75 |
Rab3c |
RAB3C, member RAS oncogene family |
79 |
0.98 |
chr7_64580354_64580580 | 11.73 |
Gm44721 |
predicted gene 44721 |
51042 |
0.12 |
chr3_5210842_5211599 | 11.69 |
Gm10748 |
predicted gene 10748 |
1618 |
0.38 |
chr2_71517791_71517985 | 11.68 |
Metap1d |
methionyl aminopeptidase type 1D (mitochondrial) |
2476 |
0.2 |
chr5_111681395_111681576 | 11.67 |
Gm26897 |
predicted gene, 26897 |
52439 |
0.11 |
chr16_41179666_41179849 | 11.66 |
Gm26381 |
predicted gene, 26381 |
37988 |
0.19 |
chr17_17402364_17402515 | 11.65 |
Lix1 |
limb and CNS expressed 1 |
233 |
0.91 |
chr2_118203496_118203665 | 11.62 |
Gm22800 |
predicted gene, 22800 |
45202 |
0.1 |
chr11_81153149_81153800 | 11.59 |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
153 |
0.97 |
chr16_90459106_90459640 | 11.59 |
Hunk |
hormonally upregulated Neu-associated kinase |
2524 |
0.3 |
chr13_119741850_119742224 | 11.57 |
Nim1k |
NIM1 serine/threonine protein kinase |
3643 |
0.15 |
chr5_16225464_16225615 | 11.56 |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
100446 |
0.07 |
chr6_23281324_23281501 | 11.56 |
C130093G08Rik |
RIKEN cDNA C130093G08 gene |
30279 |
0.15 |
chr14_55205168_55205319 | 11.53 |
Dhrs2 |
dehydrogenase/reductase member 2 |
16764 |
0.11 |
chr17_90628542_90628972 | 11.48 |
Nrxn1 |
neurexin I |
1270 |
0.58 |
chr2_33616683_33616884 | 11.48 |
Gm38011 |
predicted gene, 38011 |
2385 |
0.25 |
chr9_41736981_41737180 | 11.38 |
Gm35835 |
predicted gene, 35835 |
300 |
0.9 |
chr4_48779881_48780261 | 11.38 |
Gm24573 |
predicted gene, 24573 |
17109 |
0.19 |
chr6_112885019_112885538 | 11.36 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
55819 |
0.1 |
chr13_9847201_9847352 | 11.35 |
Gm24187 |
predicted gene, 24187 |
12751 |
0.16 |
chr15_30693718_30694224 | 11.34 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
10812 |
0.25 |
chr19_59043913_59044102 | 11.33 |
Shtn1 |
shootin 1 |
5722 |
0.22 |
chr2_61663689_61663846 | 11.33 |
Tank |
TRAF family member-associated Nf-kappa B activator |
19936 |
0.19 |
chr15_61157603_61157884 | 11.29 |
Gm38563 |
predicted gene, 38563 |
126 |
0.97 |
chr5_70842284_70842796 | 11.25 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
77 |
0.99 |
chr14_28959166_28959337 | 11.23 |
Cacna2d3 |
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
10162 |
0.23 |
chr4_91230401_91230590 | 11.20 |
Elavl2 |
ELAV like RNA binding protein 1 |
24087 |
0.23 |
chr10_57784677_57785037 | 11.19 |
Fabp7 |
fatty acid binding protein 7, brain |
24 |
0.97 |
chr18_60770031_60770182 | 11.16 |
Rps14 |
ribosomal protein S14 |
4490 |
0.15 |
chr4_77316738_77316956 | 11.15 |
Gm23159 |
predicted gene, 23159 |
358349 |
0.01 |
chr6_25013043_25013194 | 11.14 |
Gm5302 |
predicted gene 5302 |
34180 |
0.16 |
chr10_12587353_12587504 | 11.08 |
Utrn |
utrophin |
27403 |
0.24 |
chrX_143931690_143932083 | 11.07 |
Dcx |
doublecortin |
1164 |
0.61 |
chr16_77676027_77676178 | 11.05 |
Mir99ahg |
Mir99a and Mirlet7c-1 host gene (non-protein coding) |
3797 |
0.15 |
chr3_156301250_156301401 | 11.02 |
Gm42886 |
predicted gene 42886 |
36739 |
0.22 |
chr6_89013621_89013774 | 11.01 |
4933427D06Rik |
RIKEN cDNA 4933427D06 gene |
63014 |
0.09 |
chr10_9674551_9675589 | 11.00 |
Samd5 |
sterile alpha motif domain containing 5 |
138 |
0.95 |
chr3_156559909_156560264 | 10.96 |
4930570G19Rik |
RIKEN cDNA 4930570G19 gene |
1496 |
0.36 |
chr8_98365520_98365671 | 10.94 |
Gm7192 |
predicted gene 7192 |
140932 |
0.05 |
chr2_148650604_148650755 | 10.86 |
Nxt1 |
NTF2-related export protein 1 |
21922 |
0.14 |
chr11_45454907_45455258 | 10.80 |
Gm12162 |
predicted gene 12162 |
13422 |
0.27 |
chr13_114604435_114604586 | 10.79 |
4930467J12Rik |
RIKEN cDNA 4930467J12 gene |
2574 |
0.25 |
chr2_105334055_105334237 | 10.77 |
Rcn1 |
reticulocalbin 1 |
61202 |
0.12 |
chr17_13677596_13677776 | 10.74 |
Gm24867 |
predicted gene, 24867 |
2310 |
0.23 |
chr3_145825772_145825949 | 10.73 |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
15381 |
0.2 |
chr4_108779892_108781170 | 10.73 |
Zfyve9 |
zinc finger, FYVE domain containing 9 |
28 |
0.97 |
chr5_85239463_85240008 | 10.70 |
Gm21006 |
predicted gene, 21006 |
372890 |
0.01 |
chr5_129156124_129156288 | 10.70 |
Rps16-ps2 |
ribosomal protein S16, pseudogene 2 |
27689 |
0.2 |
chr11_29130348_29130606 | 10.69 |
Pnpt1 |
polyribonucleotide nucleotidyltransferase 1 |
267 |
0.92 |
chrX_16421293_16421615 | 10.67 |
Gm14516 |
predicted gene 14516 |
41807 |
0.19 |
chr3_51096724_51096891 | 10.65 |
Gm38246 |
predicted gene, 38246 |
6853 |
0.21 |
chr10_21082551_21082747 | 10.60 |
Ahi1 |
Abelson helper integration site 1 |
12804 |
0.14 |
chr7_29305318_29305484 | 10.57 |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
1425 |
0.27 |
chr6_6459403_6459593 | 10.57 |
Gm20685 |
predicted gene 20685 |
23524 |
0.18 |
chr3_38232253_38232417 | 10.54 |
Gm2965 |
predicted gene 2965 |
8884 |
0.21 |
chr1_42472391_42472897 | 10.53 |
Gm37047 |
predicted gene, 37047 |
19169 |
0.24 |
chr18_69562561_69563011 | 10.48 |
Tcf4 |
transcription factor 4 |
221 |
0.95 |
chr13_29015223_29015589 | 10.47 |
A330102I10Rik |
RIKEN cDNA A330102I10 gene |
887 |
0.68 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.3 | 42.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
5.5 | 16.5 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
4.8 | 14.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
4.4 | 8.7 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
4.0 | 15.8 | GO:0030035 | microspike assembly(GO:0030035) |
3.9 | 11.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.4 | 10.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
3.2 | 9.5 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
3.1 | 3.1 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
3.0 | 26.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
3.0 | 5.9 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
3.0 | 8.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.9 | 8.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.9 | 8.6 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
2.7 | 8.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
2.5 | 10.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
2.5 | 12.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
2.5 | 7.4 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.5 | 7.4 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
2.3 | 7.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.3 | 6.9 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
2.1 | 6.3 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
2.1 | 6.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
2.0 | 8.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
2.0 | 9.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.9 | 13.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.8 | 5.5 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.8 | 3.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.8 | 3.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.8 | 5.3 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.7 | 5.2 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.7 | 5.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.7 | 5.1 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
1.7 | 5.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.7 | 5.0 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.7 | 15.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.7 | 5.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
1.7 | 5.0 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.6 | 11.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.6 | 4.7 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.6 | 6.2 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.4 | 2.9 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.4 | 32.9 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.4 | 4.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.3 | 5.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.3 | 4.0 | GO:0030070 | insulin processing(GO:0030070) |
1.3 | 6.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.3 | 18.6 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
1.3 | 5.2 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.3 | 3.9 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.3 | 2.6 | GO:0070672 | response to interleukin-15(GO:0070672) |
1.3 | 3.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.3 | 11.4 | GO:0050957 | equilibrioception(GO:0050957) |
1.3 | 5.1 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
1.2 | 2.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.2 | 3.6 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
1.2 | 3.6 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
1.2 | 12.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
1.1 | 5.7 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
1.1 | 5.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.1 | 3.4 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.1 | 4.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.1 | 3.3 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.1 | 1.1 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
1.1 | 8.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.1 | 4.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.1 | 3.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
1.1 | 3.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.1 | 8.5 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
1.1 | 4.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.0 | 3.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.0 | 3.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.0 | 5.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.0 | 10.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
1.0 | 3.0 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
1.0 | 4.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.0 | 2.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.0 | 2.0 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
1.0 | 4.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.0 | 4.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.0 | 4.9 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.0 | 3.9 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.0 | 4.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.0 | 2.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 6.5 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.9 | 1.9 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.9 | 2.8 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.9 | 18.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.9 | 9.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.9 | 19.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.9 | 1.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.9 | 14.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.9 | 3.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.9 | 3.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.9 | 4.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.9 | 7.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.9 | 0.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.8 | 2.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.8 | 2.5 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.8 | 3.4 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.8 | 2.5 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.8 | 4.2 | GO:0046618 | drug export(GO:0046618) |
0.8 | 5.0 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.8 | 3.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.8 | 2.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.8 | 3.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.8 | 8.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.8 | 4.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.8 | 2.4 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.8 | 1.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.8 | 3.1 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.8 | 0.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.8 | 1.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.8 | 2.3 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.7 | 15.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.7 | 12.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.7 | 0.7 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.7 | 2.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.7 | 2.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.7 | 2.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.7 | 4.4 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.7 | 6.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.7 | 2.9 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.7 | 3.6 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.7 | 2.8 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.7 | 1.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.7 | 2.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.7 | 2.8 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.7 | 2.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.7 | 2.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.7 | 1.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.7 | 2.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.7 | 3.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.7 | 6.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 4.6 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.7 | 0.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.7 | 2.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.7 | 3.9 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.6 | 2.6 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.6 | 1.3 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.6 | 7.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.6 | 1.3 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.6 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.6 | 1.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.6 | 7.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 1.2 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.6 | 2.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.6 | 5.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.6 | 3.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 8.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.6 | 6.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 2.9 | GO:0070842 | aggresome assembly(GO:0070842) |
0.6 | 2.3 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.6 | 1.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 1.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.6 | 4.4 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.6 | 4.4 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.5 | 2.7 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.5 | 2.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.5 | 15.8 | GO:0003407 | neural retina development(GO:0003407) |
0.5 | 7.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.5 | 3.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 0.5 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 4.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.5 | 1.6 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.5 | 2.7 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.5 | 1.6 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 1.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.5 | 1.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.5 | 2.6 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.5 | 3.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.5 | 0.5 | GO:0060066 | oviduct development(GO:0060066) |
0.5 | 35.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 1.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 2.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 1.0 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 1.5 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 8.6 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 1.5 | GO:0061038 | uterus morphogenesis(GO:0061038) |
0.5 | 2.0 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.5 | 1.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.5 | 2.0 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.5 | 5.0 | GO:0006266 | DNA ligation(GO:0006266) |
0.5 | 1.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.5 | 0.5 | GO:0021756 | striatum development(GO:0021756) |
0.5 | 0.5 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.5 | 0.5 | GO:0060594 | mammary gland specification(GO:0060594) |
0.5 | 6.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.5 | 1.5 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 2.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.5 | 1.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 1.0 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.5 | 1.4 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.5 | 5.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.5 | 3.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.5 | 1.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 0.9 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.5 | 3.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.5 | 11.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.5 | 1.8 | GO:0051031 | tRNA transport(GO:0051031) |
0.5 | 0.9 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.5 | 1.4 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.5 | 0.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 1.4 | GO:0061055 | myotome development(GO:0061055) |
0.5 | 2.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.4 | 0.9 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.4 | 1.3 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 1.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.4 | 0.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.4 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.3 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.4 | 0.9 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.4 | 0.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 4.7 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.4 | 0.4 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.4 | 1.2 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.4 | 0.4 | GO:0060174 | limb bud formation(GO:0060174) |
0.4 | 8.7 | GO:0097576 | vacuole fusion(GO:0097576) |
0.4 | 2.9 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.4 | 0.4 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.4 | 0.8 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.4 | 2.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.4 | 0.8 | GO:0006868 | glutamine transport(GO:0006868) |
0.4 | 1.2 | GO:0060931 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.4 | 2.0 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 2.4 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 0.4 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.4 | 1.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.4 | 1.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 0.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 3.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.4 | 1.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 0.4 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.4 | 10.0 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.4 | 1.5 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.4 | 4.0 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.4 | 8.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.4 | 4.7 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.4 | 3.6 | GO:0007625 | grooming behavior(GO:0007625) |
0.4 | 0.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.4 | 1.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 0.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 1.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.3 | 1.4 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.3 | 1.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 3.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.3 | 1.7 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.3 | 4.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.3 | 0.3 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.3 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 1.3 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 3.0 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 0.7 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.3 | 0.7 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.3 | 0.3 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
0.3 | 2.3 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.3 | 1.3 | GO:0030091 | protein repair(GO:0030091) |
0.3 | 1.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 0.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.3 | 1.0 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 2.6 | GO:0001964 | startle response(GO:0001964) |
0.3 | 1.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.3 | 0.3 | GO:0048880 | sensory system development(GO:0048880) |
0.3 | 0.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 0.9 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.3 | 8.0 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.3 | 0.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 1.5 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.3 | 0.6 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.3 | 0.9 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.3 | 0.3 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
0.3 | 1.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 0.6 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.3 | 1.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 1.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 2.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 0.9 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 0.6 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 0.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 3.1 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.3 | 0.3 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.3 | 2.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 1.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 0.3 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.3 | 0.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.3 | 1.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.3 | 1.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 11.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 0.3 | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.3 | 1.4 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 1.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.3 | 0.8 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 1.9 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.3 | 1.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 0.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.3 | 0.8 | GO:0060618 | nipple development(GO:0060618) |
0.3 | 1.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 0.5 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 0.5 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.3 | 1.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.3 | 0.3 | GO:0035483 | gastric emptying(GO:0035483) |
0.3 | 2.7 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.3 | 1.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 6.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 0.5 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.3 | 1.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.3 | 1.8 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 1.8 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 0.8 | GO:0044849 | estrous cycle(GO:0044849) |
0.3 | 1.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.3 | 0.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.3 | 2.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.3 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.8 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.3 | 1.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.5 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.3 | 1.0 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 1.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.2 | 0.5 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 1.5 | GO:0051255 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 3.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 0.7 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.7 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 0.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 1.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 1.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.2 | 2.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 7.9 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.2 | 0.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.9 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.2 | 0.2 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.2 | 2.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 1.9 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 1.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.2 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 1.4 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.2 | 1.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 1.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.2 | 3.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.4 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.2 | 1.1 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.2 | 0.4 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 2.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 0.7 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.2 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.2 | 0.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 1.7 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 1.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.9 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 0.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.4 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 2.5 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 0.4 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 0.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.2 | 1.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 0.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 2.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 0.8 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.2 | 0.8 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.2 | 0.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.2 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.2 | 0.6 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 1.0 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 1.0 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 2.2 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.2 | 0.7 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 2.2 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.2 | 0.7 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.2 | 0.9 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 0.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 0.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 0.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.5 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.2 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.2 | 0.7 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.2 | 0.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.2 | 0.5 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 1.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.2 | 1.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.2 | 0.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.2 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 0.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 0.3 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 1.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.3 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.2 | 1.4 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.2 | 0.5 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 1.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.2 | 0.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 1.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 2.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.1 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.9 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.7 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 1.6 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.3 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.1 | 0.3 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.1 | 0.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.6 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 1.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.1 | 0.8 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 1.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 1.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.5 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.1 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.1 | 0.8 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 1.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 1.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 1.3 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.4 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 1.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.2 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.5 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.3 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.2 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 | 0.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.1 | 0.3 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.6 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.1 | 0.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.7 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 1.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 1.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.3 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.6 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 3.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:0097503 | sialylation(GO:0097503) |
0.1 | 0.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 1.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.4 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.2 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.1 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
0.1 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.1 | 0.1 | GO:1903909 | regulation of receptor clustering(GO:1903909) positive regulation of receptor clustering(GO:1903911) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.4 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 1.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.2 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.6 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.1 | 0.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.2 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.1 | 0.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 2.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.2 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.5 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.4 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.1 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.3 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 0.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 0.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.1 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.1 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.2 | GO:0071907 | determination of pancreatic left/right asymmetry(GO:0035469) determination of digestive tract left/right asymmetry(GO:0071907) determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.1 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.2 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.1 | 0.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.5 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.1 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.1 | 0.1 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.1 | 0.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 2.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.4 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.1 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.1 | 0.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 0.2 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.1 | 0.3 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.1 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.8 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.1 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 1.2 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.1 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.1 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.1 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.1 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.1 | 0.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:2001274 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 1.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.1 | 0.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.1 | GO:0051231 | spindle elongation(GO:0051231) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0071864 | positive regulation of cell proliferation in bone marrow(GO:0071864) |
0.1 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
0.0 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.0 | 0.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.0 | 0.2 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.1 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.0 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.0 | 0.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.2 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.1 | GO:0061323 | cell proliferation involved in heart morphogenesis(GO:0061323) |
0.0 | 0.3 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.0 | 0.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.0 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.8 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.0 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.0 | 0.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.0 | 0.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.1 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.0 | 0.9 | GO:0048536 | spleen development(GO:0048536) |
0.0 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.0 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.2 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.0 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.2 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.0 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.0 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.0 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.0 | 0.0 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.0 | 0.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.0 | 0.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.0 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.1 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.0 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.0 | 0.1 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.0 | GO:0035933 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.0 | 0.1 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.4 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.1 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.0 | 0.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.0 | 0.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.0 | GO:0071870 | cellular response to catecholamine stimulus(GO:0071870) |
0.0 | 0.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.1 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.2 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.0 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.0 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.0 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.0 | 0.2 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.5 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.4 | 17.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.2 | 21.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.9 | 15.2 | GO:0043083 | synaptic cleft(GO:0043083) |
1.9 | 7.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
1.8 | 3.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.8 | 8.9 | GO:0097433 | dense body(GO:0097433) |
1.6 | 11.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.5 | 11.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
1.4 | 4.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
1.4 | 8.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.4 | 4.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
1.4 | 8.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
1.3 | 5.4 | GO:1990357 | terminal web(GO:1990357) |
1.3 | 4.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.3 | 60.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.3 | 21.0 | GO:0030673 | axolemma(GO:0030673) |
1.3 | 5.2 | GO:0033269 | internode region of axon(GO:0033269) |
1.2 | 14.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.2 | 35.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.1 | 3.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.0 | 7.3 | GO:0016342 | catenin complex(GO:0016342) |
1.0 | 2.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.0 | 3.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.9 | 2.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.8 | 2.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.8 | 12.8 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.7 | 1.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.7 | 2.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 2.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.6 | 2.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 5.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.6 | 9.6 | GO:0043205 | fibril(GO:0043205) |
0.6 | 1.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.6 | 9.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 1.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.6 | 3.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 3.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.6 | 7.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.5 | 4.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.5 | 1.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.5 | 4.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 7.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.5 | 5.2 | GO:0042555 | MCM complex(GO:0042555) |
0.5 | 4.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.5 | 5.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 0.9 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.5 | 1.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.5 | 13.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.5 | 1.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 0.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 1.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 1.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 3.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.4 | 0.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.4 | 2.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 4.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 3.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 1.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 10.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 5.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 1.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.4 | 0.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 7.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 8.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.3 | 1.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.3 | 1.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 16.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 45.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 1.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 3.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 1.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 1.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 1.8 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.3 | 1.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 1.5 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 2.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 1.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 24.7 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 1.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.7 | GO:0000801 | central element(GO:0000801) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 0.9 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 6.0 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 3.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.8 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 0.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 2.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 1.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 1.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 0.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.5 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 1.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 2.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 1.1 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.7 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 2.2 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.8 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.4 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.1 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.2 | GO:0005818 | aster(GO:0005818) |
0.1 | 1.6 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 1.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 3.2 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.8 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 2.0 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 1.2 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.5 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 1.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 1.2 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 4.0 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.2 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 4.9 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.6 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 18.0 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 6.0 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.7 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 4.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.0 | GO:0097513 | myosin II filament(GO:0097513) |
0.0 | 1.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.1 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.1 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.1 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.0 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 1.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.0 | 24.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
5.6 | 16.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
5.4 | 10.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
3.9 | 11.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.7 | 8.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.5 | 7.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
2.4 | 19.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
2.2 | 6.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.1 | 6.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
2.0 | 9.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.9 | 7.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.9 | 7.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.8 | 12.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
1.7 | 8.7 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
1.7 | 11.7 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
1.6 | 19.3 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.5 | 9.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.5 | 4.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.4 | 5.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.4 | 12.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.3 | 19.9 | GO:0035198 | miRNA binding(GO:0035198) |
1.3 | 3.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.3 | 3.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.3 | 16.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.2 | 5.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.2 | 3.7 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.2 | 6.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.2 | 5.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.1 | 16.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.1 | 3.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.1 | 11.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.1 | 4.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.0 | 8.1 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.0 | 4.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.9 | 12.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.9 | 4.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.9 | 9.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.9 | 4.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.9 | 2.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.9 | 6.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.9 | 4.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.9 | 2.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.9 | 2.7 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.9 | 8.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.8 | 2.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 1.7 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.8 | 5.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.8 | 12.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.8 | 2.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.8 | 2.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.7 | 2.2 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.7 | 2.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.7 | 13.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.7 | 13.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.7 | 14.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.7 | 6.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.7 | 3.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.6 | 3.2 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.6 | 9.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.6 | 13.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.6 | 2.5 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.6 | 3.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.6 | 1.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 3.6 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.6 | 1.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.6 | 2.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.6 | 2.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.6 | 2.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 2.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.6 | 1.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.6 | 9.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 2.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 2.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.5 | 1.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 2.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 1.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.5 | 3.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 2.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 5.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.5 | 5.5 | GO:0048185 | activin binding(GO:0048185) |
0.5 | 1.5 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 2.0 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 2.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.5 | 4.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 1.9 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 10.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.5 | 0.9 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.4 | 1.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.4 | 0.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 0.9 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.4 | 4.0 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 7.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.4 | 2.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 1.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 10.0 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 0.8 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 12.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 8.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 2.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.4 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.4 | 0.4 | GO:0008579 | JUN kinase phosphatase activity(GO:0008579) |
0.4 | 1.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 2.5 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.4 | 3.6 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 7.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 10.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.4 | 1.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 1.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 0.7 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.4 | 1.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 1.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 1.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 0.7 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.3 | 3.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 1.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 1.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 3.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 1.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 2.4 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 1.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.3 | 1.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 1.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 1.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.3 | 1.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 6.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 0.3 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.3 | 0.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 1.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 2.7 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.3 | 2.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 11.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.3 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 2.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.4 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 2.8 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 1.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 2.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 0.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 1.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.3 | 2.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 2.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 1.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 0.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 1.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 2.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 21.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.3 | 2.5 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.3 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 0.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 0.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 7.2 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.2 | 1.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 1.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.5 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 1.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 2.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.2 | GO:0008193 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.2 | 0.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 2.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 5.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 1.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 2.4 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 2.4 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 1.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 1.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 0.9 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.2 | 7.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.2 | 1.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 1.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.2 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 1.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.2 | 0.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 3.9 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.2 | 2.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 11.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.2 | 2.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.2 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 2.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 1.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.5 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 0.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 4.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 2.1 | GO:0022841 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.1 | 0.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.4 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.7 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 1.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 1.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.4 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 1.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 1.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.5 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.1 | 0.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 1.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.6 | GO:0052760 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.1 | 6.2 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.3 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 1.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.4 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 3.6 | GO:0034930 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.1 | 0.6 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 2.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.3 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 2.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 2.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 2.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.3 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.7 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 0.6 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 1.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 1.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.7 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.5 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 1.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.2 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 1.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 1.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 1.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.2 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 0.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.0 | 0.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.2 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.5 | GO:0044688 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.0 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 1.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 1.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.1 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.0 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.0 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.0 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.0 | 0.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.0 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.0 | 4.8 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 4.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.2 | 17.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.5 | 7.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 12.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 0.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 5.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 10.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 1.4 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 8.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 1.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.3 | 21.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 1.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 5.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 4.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 3.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 8.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 2.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 3.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.2 | 2.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 1.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 3.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 4.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 3.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 3.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 3.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 2.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 0.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.8 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 7.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 2.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.7 | 17.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.6 | 35.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.2 | 13.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
1.1 | 1.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.0 | 2.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
1.0 | 2.9 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.8 | 17.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 9.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.7 | 0.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.7 | 10.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.7 | 7.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.7 | 7.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.6 | 3.7 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.6 | 11.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.6 | 4.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.5 | 3.3 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.5 | 6.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 4.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.5 | 6.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 9.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 0.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.4 | 6.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.4 | 3.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 3.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.4 | 6.9 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 3.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 5.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.4 | 0.8 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
0.4 | 6.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.4 | 3.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 5.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 1.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 1.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.3 | 13.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 4.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.3 | 2.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 0.9 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 4.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 4.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 2.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 2.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 2.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 1.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 1.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 0.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 6.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 2.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 2.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 1.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 2.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 3.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 1.7 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 4.7 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 0.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 1.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 2.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 2.0 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 5.9 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.5 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 2.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.4 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 4.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 0.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 1.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.1 | 0.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |